08:58 AM EDT, 06/20/2024 (MT Newswires) -- Health care stocks were steady pre-bell Thursday as the Health Care Select Sector SPDR Fund (XLV) was down 0.2% while iShares Biotechnology ETF (IBB) was recently unchanged.

Jazz Pharmaceuticals ( JAZZ ) was down more than 2% after saying its investigational therapy suvecaltamide did not meet its primary endpoint in a phase 2b trial evaluating its efficacy and safety in adult patients with essential tremor.